Select Medical (NYSE:SEM) Given New $21.00 Price Target at UBS Group

Select Medical (NYSE:SEM) had its price objective reduced by UBS Group from $40.00 to $21.00 in a report released on Friday morning,Benzinga reports. They currently have a neutral rating on the health services provider’s stock.

SEM has been the subject of several other reports. Benchmark downgraded Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, November 25th. Royal Bank of Canada raised their price objective on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Finally, StockNews.com cut shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, December 30th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $39.50.

Select Medical Price Performance

Select Medical stock opened at $18.40 on Friday. Select Medical has a one year low of $18.02 and a one year high of $40.98. The stock’s fifty day moving average price is $26.91 and its two-hundred day moving average price is $32.21. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The firm has a market cap of $2.38 billion, a PE ratio of 8.60, a price-to-earnings-growth ratio of 0.39 and a beta of 1.43.

Select Medical (NYSE:SEM) last issued its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.07. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The company’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter last year, the company posted $0.46 EPS. As a group, research analysts expect that Select Medical will post 1.97 EPS for the current fiscal year.

Select Medical Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th were given a dividend of $0.125 per share. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 2.72%. Select Medical’s payout ratio is presently 23.36%.

Insider Buying and Selling

In other Select Medical news, Director Marilyn B. Tavenner sold 32,000 shares of the company’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the transaction, the director now owns 22,000 shares in the company, valued at $463,980. This represents a 59.26 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the company’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the transaction, the vice president now owns 30,356 shares in the company, valued at approximately $605,602.20. The trade was a 14.12 % decrease in their position. The disclosure for this sale can be found here. 19.14% of the stock is owned by insiders.

Hedge Funds Weigh In On Select Medical

Institutional investors have recently added to or reduced their stakes in the business. Natixis Advisors LLC boosted its stake in shares of Select Medical by 11.7% in the 2nd quarter. Natixis Advisors LLC now owns 26,460 shares of the health services provider’s stock valued at $928,000 after purchasing an additional 2,778 shares in the last quarter. Rhumbline Advisers boosted its position in Select Medical by 2.6% during the second quarter. Rhumbline Advisers now owns 327,170 shares of the health services provider’s stock valued at $11,471,000 after buying an additional 8,194 shares during the period. TD Asset Management Inc bought a new position in shares of Select Medical during the second quarter valued at about $926,000. Foster & Motley Inc. increased its holdings in shares of Select Medical by 3.1% in the second quarter. Foster & Motley Inc. now owns 12,147 shares of the health services provider’s stock worth $426,000 after buying an additional 370 shares during the period. Finally, Arizona State Retirement System boosted its holdings in Select Medical by 2.0% during the 2nd quarter. Arizona State Retirement System now owns 30,544 shares of the health services provider’s stock valued at $1,071,000 after acquiring an additional 593 shares during the period. 89.48% of the stock is currently owned by institutional investors.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.